Executives On The Move: UCB, LAVA Therapeutics and More
Recent executive moves in the industry include C-suite changes at Arcus Biosciences and UCB. Meanwhile, new directors were appointed at Arovella Therapeutics and LAVA Therapeutics.
You may also be interested in...
Recent moves within the industry include changes at the top for Ocular Therapeutix and Rayzebio, plus a new CEO for Bellicum Pharmaceuticals.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
Recent executive moves in the industry include new CEOs at Latigo Biotherapeutics and YS Biopharma Co, plus new directors at Cingulate.